General network of natural autoantibodies as immunological homunculus (Immunculus)

Autoimmunity Reviews

Volumn 2, Issue 5, 2003, Pages 264-271

  Poletaev, Alexander ^a,b   Osipenko, Leeza ^a  

^a Medical Research Center 'Immunculus'   (Russian Federation)

^b Apt 159 ^*  (Russian Federation)

Author keywords

Immunculus; Immune regulation of physiological functions; Natural autoantibodies' repertoires

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNITY; CYTOPLASM; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; PHYSIOLOGY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVIEW;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; HUMANS; IMMUNE SYSTEM;

EID: 0042261939     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00033-8     Document Type: Review

References (40)

1. Galaktionov V.V. Immunology. 1998;Moscow University Publishers, Moscow.
2. Haitov P.M., Ignateva G.A., Sidorovich I.G. Immunology. 2000;Meditsina, Moscow.
3. Besredka M. Les antihemolysines naturelles. Ann Inst Pasteur. 15:1901;758-763.
4. Jerne N.K. Towards a network theory of the immune system. Ann Immunol (Inst Pasteur). 125:1974;373-389.
5. Lacroix-Desmazes S., Kaveri S.V., Mouthon L., et al. Self-reactive natural autoantibodies in healthy individuals. J Immunol Meth. 216:1998;117-137.
6. Poletaev A.B. Regulatory autoantibodies. Shtark M.B., Starostina M.V. Monoclonal antibodies in neurobiology. 1995;37-45 Aspekt, Novosibirsk.
7. Casali P., Notkins A.L. CD5+ B-lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today. 10:1989;364-368.
8. Bendtzen K., Svenson M., Jonsson V., Hippe E. Autoantibodies to cytokines-friends or foes? Immunol Today. 11:1990;167-169.
9. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today. 12:1991;154-158.
10. Vabyschevich N.K., Poletaev A.B., Budykina T.S., Zamaleeva R.S. The immune imprinting. Meditsinskaya Konsultatsiya, Russian; (Medical Consultation). 2:1998;14-17.
11. Coutinho A. Simple developmental programs of gene expression and cellular composition of lymphoid organs at the origin of natural tolerance. Res Immunol. 146:1995;321-332.
12. Teppermen J., Teppermen H. Physiology of the general metabolism and endocrine system. 1989;Mir, Moscow.
13. Heath R.G., Krupp I.M., Byers L.W., Liljekvist J.I. Schizophrenia as an immunologic disorder. Effect of anti-monkey and anti-human brain antibody on brain function. Arch Gen Psychiatry. 16:1967;24-33.
14. Knight J.G., Knight A., Menkes D.B., Mullen P.E. Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia? Biol Psychiat. 28:1990;467-474.
15. Cohen I.R., Young D.B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today. 12:1991;105-110.
16. Poletaev A.B. The immunological homunculus (Immunculus) in norm and pathology. Biochemistry (Moscow). 67:2002;600-608.
17. Gonzales G., Montero E., Leon K., Cohen I.R., Lage A. Autoimmunization to EGF, a component of the immunological homunculus. Autoimmun Rev. 1:2002;89-95.
18. Poletaev A.B., Morozov S.G. Changes of maternal serum natural antibodies of IgG class to proteins MBP, S100, ACBP14/18 and MP65 and embryonic misdevelopments in humans. Hum Antibody. 9:2000;216-222.
19. Poletaev A.B., Morozov S.G., Gnedenko B.B., Zlunikin V.M., Korzhenevsky D.A. Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders. Autoimmunity. 32:2000;33-38.
20. Norendran A., Hoffman S.A. Characterization of brain-reactive antibodies in murine model of SLE. J Neuroimmunol. 24:1989;113-123.
21. Kovalev I.E., Polevaya O.Y. Biochemical principles of immunity against low-molecular-weight chemical compounds. 1985;Nauka, Moscow.
22. Poletaev A.B., Budykina T.S., Gnedenko B.B., Kluchnikov S.O. Regulatory metasystem and children's neuropathology. Meditsinskaya Konsultatsiya, Russian; (Medical Consultation). 4:1998;1-4.
23. Kulberg A.Y. Molecular immunology. 1986;Meditsina, Moscow.
24. Grabar P.N. Autoantibodies and immunologic theories. Onthogenesys. 6:1975;115-126.
25. Wang B.S., Lumanglas A.L., Szewczyk E., McWilliams W., Loullis C.S., Hart I.C. A proposed mechanism of action of a growth hormone-specific monoclonal antibody in the enhancement of hormonal activity. Mol Immunol. 29:1992;313-316.
26. Borovski A., Gyling M., Muquardt C., Body I.I., Leclercq G. Estrogen-like activity of a subpopulation of natural antiestrogen receptor autoantibodies in man. Endocrinology. 128:1991;3283-3292.
27. Azizov RG, Immunopharmacological investigations of the neural-immune interactions. Doctoral Thesis, Staraya Kupavna: NII po BIKhS RAN, 1997.
28. Barhanin J., Meiri H., Romey G., Pauron D., Lazdunski M. A monoclonal immunotoxin acting on the Na-channel, with properties similar to those of scorpion toxin. Proc Natl Acad Sci USA. 82:1985;1842-1846.
29. Sher E., Canal N., Piccolo G., et al. Thyrotropin-receptor-mediated diseases: a paradigm for receptor autoimmunity. Immunol Today. 18:1997;437-440.
30. Zaitchik A.S., Churilov L.P. General pathophysiology. 2001;ELBI-SPb, St. Petersburg.
31. Landor M. Maternal-fetal transfer of immunoglibulins. Ann Allergy Asthma Immunol. 74:1995;279-283.
32. Isenberg D.A., Rahman M.A., Ravikarjan C.T., Kalsi J.K. Anti-DNA antibodies: from gene usage to cristal structures. Immunol Today. 18:1997;149-153.
33. Burlet A.J., Leon-Henry B.P., Robert F.R. Monoclonal anti-vasopressin (VP) antibodies penetrate VP neurons in vivo. Exp Brain Res. 65:1987;629-638.
34. Albeck D., Rose G.M., Veng L. Electrophysiological effects of OX-26-NGF on medial septal neurons. Soc Neurosci Abstr. 22:1996;752.
35. Maliartchouk S., Zheng W.-H., Saragovi H.U. Balancing the Th1/Th2 concept in multiple sclerosis. Immunol Today. 19:1998;489-490.
36. k antibodies to oligodendrocytes promotes CNS renyelination. J Neurosci. 18:1998;7700-7708.
37. Prabhakar B.S., Fan J.L., Seetharamaiah G.S. Thyrotropin-receptor-mediated diseases: a paradigm for receptor autoimmunity. Immunol Today. 18:1997;437-440.
38. Kusch A.A., Beljavsky A.V., Shumaj E.P., Tugizov S.M. Monoclonal antibodies against topoizomerase-I as inhibitors of G1 phase of cell cycle. Doklady AN USSR. 300:1988;968-970.
39. Ageenko A.I. The face of cancer. 1994;Meditsina, Moscow.
40. Mechnikoff E. Immunity in infective diseases. New York: Johnson. Reprint, 1968 (original published 1901).